GE Healthcare is talking to buy Sofie Biosciences for $1B to boost its pharmaceutical diagnostics. But recent quarter showed stalled growth and free cash flow of $68M, so the story does not change the company's picture.
GE Healthcare is in talks to buy Sofie Biosciences for $1B, which could strengthen its pharmaceutical diagnostics. The company also reported stalled revenue growth and free cash flow of $68M, so the news balances out.
The article only mentions General Electric as GE Healthcare's former parent. The story focuses on GE Healthcare's possible purchase and does not change GE's picture.
Follow GE Healthcare Technologies (GEHC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GEHC